Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antigen Specificity Enhances Disease Control by Tregs in Vitiligo

Frontiers in Immunology(2020)10.3389/fimmu.2020.581433Source: DataRank Database

Antigen Specificity Enhances Disease Control by Tregs in Vitiligo is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 76 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access76 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 3.13)OA: goldTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Emilia R. Dellacecca ORCID,Cormac Cosgrove ORCID,Rohan Shivde ORCID,Dinesh Jaishankar ORCID,Katherine Pontarolo-Maag

Live enrichment

PubMed:33335528 PMC:PMC7736409 OpenAlex:https://openalex.org/W3110590410

National Institutes of Health

Grant: RO1-AR057643-01A2, R01-CA191317-01A1

NCI NIH HHS

Grant: R01 CA236379

NCI NIH HHS

Grant: R01 CA191317

NIAMS NIH HHS

Grant: R01 AR057643

National Institutes of Health

Grant: 5R01CA191317-05

Separating autoimmunity and anti-tumor immunity

National Institutes of Health

Grant: 1R01AR057643-01A2

Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo

FWCI

3.13

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fimmu.2020.581433

publisherhttps://doi.org/10.3389/fimmu.2020.581433

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.581433/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33335528

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7736409

Fields of Study

melanin and skin pigmentationT-cell and B-cell ImmunologyAtherosclerosis and Cardiovascular Diseases0301 basic medicine03 medical and health sciences

MeSH Terms

Receptors, Chimeric AntigenEpidermal CellsAnimalsAntigensAutoimmune DiseasesHumansMelanocytesMice, TransgenicSkinVitiligoAutoimmunityInterleukin-10T-Lymphocytes, RegulatoryMice

Keywords

VitiligoDepigmentationImmunologyAntigenMedicineT-cell receptorAutoimmune diseaseChimeric antigen receptorImmune systemImmunotherapyT cellAntibodyDermatologyAutoimmune diseasesRegulatory T cellsAntigen-specific TregChimeric Antigen Receptor T CellsGanglioside D3AutoimmunityMice, TransgenicT-Lymphocytes, RegulatoryMiceAnimalsHumansAntigensSkinReceptors, Chimeric AntigenRC581-607Interleukin-10Epidermal CellsMelanocytesImmunologic diseases. Allergy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Antigen Specificity Enhances Disease Control by Tregs in Vitiligo

FAIR Checklist

Authors (16)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)